Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Rad

Showing results (151-160 of 210) with videos related to

Pageof 21
Sort By:
Nature Protocols|March 15, 2022
CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liverThorsten Kaltenbacher, Jessica Löprich, Roman Maresch, et al.
Nature Communications|February 27, 2016
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in miceRoman Maresch, Sebastian Mueller, Christian Veltkamp, et al.
JHEP Reports : Innovation in Hepatology|October 27, 2021
Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5pSuzanne Faure-Dupuy, Tobias Riedl, Maude Rolland, et al.
Gastroenterology|July 23, 2022
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic PancreatitisUjjwal M Mahajan, Bettina Oehrle, Simon Sirtl, et al.
Nature Communications|March 7, 2023
Non-canonical functions of SNAIL drive context-specific cancer progressionMariel C Paul, Christian Schneeweis, Chiara Falcomatà, et al.
Cell Reports. Medicine|September 1, 2023
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapySimon Heidegger, Florian Stritzke, Sarah Dahl, et al.
Cell Reports. Medicine|January 21, 2026
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancersJulian Frädrich, Carmen Mota Reyes, Michel Hendel, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Immunity|June 14, 2023
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 26, 2021
Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ RegenerationFrank Arnold, Pallavi U Mahaddalkar, Johann M Kraus, et al.
Pageof 21

Showing results (151-160 of 210) with videos related to

Sort By:
Pageof 21
Nature Protocols|March 15, 2022
CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liverThorsten Kaltenbacher, Jessica Löprich, Roman Maresch, et al.
Nature Communications|February 27, 2016
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in miceRoman Maresch, Sebastian Mueller, Christian Veltkamp, et al.
JHEP Reports : Innovation in Hepatology|October 27, 2021
Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5pSuzanne Faure-Dupuy, Tobias Riedl, Maude Rolland, et al.
Gastroenterology|July 23, 2022
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic PancreatitisUjjwal M Mahajan, Bettina Oehrle, Simon Sirtl, et al.
Nature Communications|March 7, 2023
Non-canonical functions of SNAIL drive context-specific cancer progressionMariel C Paul, Christian Schneeweis, Chiara Falcomatà, et al.
Cell Reports. Medicine|September 1, 2023
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapySimon Heidegger, Florian Stritzke, Sarah Dahl, et al.
Cell Reports. Medicine|January 21, 2026
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancersJulian Frädrich, Carmen Mota Reyes, Michel Hendel, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Immunity|June 14, 2023
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 26, 2021
Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ RegenerationFrank Arnold, Pallavi U Mahaddalkar, Johann M Kraus, et al.
Pageof 21